Adaptive Biotechnologies Corp (ADPT)
Healthcare
Diagnostics & Research
22.60 $
-6.7%
vs. previous close
Closing price · As of: 31. Jul 2026
Adaptive Biotechnologies Corp (ADPT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -9.5 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -24 | -47 | -27 | -38 | -17 | -27 | -12 | -28 | -12 | -7.1 | 2.1 | -9.5 | -27 | |
| 7.5 | 7.6 | 5.4 | 5.2 | 5.0 | 4.6 | 4.4 | 4.7 | 4.5 | 4.4 | 4.2 | 3.8 | 17 | |
| 17 | 15 | 16 | 14 | 13 | 14 | 13 | 12 | 13 | 13 | 13 | 12 | 51 | |
| 18 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 0.4 | -19 | -3.5 | -10 | 2.8 | -13 | 3.1 | -16 | -5.3 | -34 | -2.5 | -6.3 | -48 | |
| 3.7 | 2.8 | 1.3 | 1.5 | 1.7 | 0.3 | 0.1 | 1.3 | 0.7 | 0.4 | 0.6 | 0.8 | 2.5 | |
| 37 | 26 | 3.2 | 45 | 5.9 | 5.3 | 22 | 26 | 3.3 | 17 | -8.3 | 9.1 | 22 | |
| 1.5 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.1 | 5.5 | 1.6 | 1.7 | 22 | 7.5 | 32 | |
| 15 | -21 | -24 | 6.2 | -11 | -22 | 9.8 | 2.7 | -7.5 | 12 | 15 | 7.1 | 27 | |
| -27 | -49 | -28 | -40 | -19 | -27 | -13 | -30 | -13 | -7.5 | 1.4 | -10 | -30 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.